Glycomin 5 Mg Tablets 5 mg Tablets
PDF Leaflet Revision Date: 26 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct treatment for Type II diabetes when diet alone is insufficient.
Dosage (summary)
Initial dose: 2.5 mg daily, may increase to 15 mg daily.
Special Populations
- Elderly may require smaller doses
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Increased risk of cardiovascular mortality with biguanides
- Hypoglycaemic effects enhanced by antibiotics and anticoagulants
Contraindications
- Hypersensitivity to sulphonylureas
- Insulin-dependent diabetes
- Severe renal or hepatic impairment
- Diabetes with ketoacidosis
Common side effects
- Hypoglycaemia
- Weight gain
- Gastrointestinal disturbances
Counselling Points
- Take with or immediately after meals to reduce hypoglycaemia risk
- Report signs of hypoglycaemia immediately
- Avoid alcohol consumption
Serious warnings
- Increased cardiovascular mortality risk
- May impair ability to drive or operate machinery
Important Disclaimer
The Glycomin 5 Mg Tablets 5 mg Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
